{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:36:24Z","timestamp":1791851784463,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.thorsurg.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T23:11:08Z","timestamp":1542409868000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Current Medical Management of Pulmonary Tuberculosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Robert W.","family":"Belknap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2018.09.004_bib1","unstructured":"World Health Organization. Global tuberculosis report. Geneva (Switzerland): WHO; 2017."},{"key":"10.1016\/j.thorsurg.2018.09.004_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/JCM.41.1.359-367.2003","article-title":"Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping","volume":"41","author":"Zink","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib3","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6711a2","article-title":"Tuberculosis \u2014 United States, 2017","volume":"67","author":"Stewart","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib5","doi-asserted-by":"crossref","first-page":"e17601","DOI":"10.1371\/journal.pone.0017601","article-title":"Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review","volume":"6","author":"Tiemersma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5588\/pha.13.0024","article-title":"Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review","volume":"3","author":"Harries","year":"2013","journal-title":"Public Health Action"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib8","unstructured":"Daley C, Gotway M, Jasmer R. Radiographic manifestations of tuberculosis. 2011. Available at: http:\/\/www.currytbcenter.ucsf.edu\/topics-interest\/tb-radiology. Accessed October 7, 2018."},{"key":"10.1016\/j.thorsurg.2018.09.004_bib9","doi-asserted-by":"crossref","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","article-title":"PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis","volume":"6","author":"Coleman","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib10","doi-asserted-by":"crossref","first-page":"e1005739","DOI":"10.1371\/journal.ppat.1005739","article-title":"PET CT identifies reactivation risk in cynomolgus macaques with latent M. tuberculosis","volume":"12","author":"Lin","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MCP.0000000000000043","article-title":"Advances in imaging of tuberculosis: the role of (1)(8)F-FDG PET and PET\/CT","volume":"20","author":"Vorster","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib13","first-page":"485","article-title":"Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review","volume":"11","author":"Mase","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/516782","article-title":"Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate","volume":"44","author":"Brown","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cid\/ciw035","article-title":"Evaluation of Xpert MTB\/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings","volume":"62","author":"Luetkemeyer","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib16","first-page":"3126","article-title":"Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis","volume":"7","author":"Gui","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib18","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib19","unstructured":"World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva (Switzerland): WHO; 2017."},{"key":"10.1016\/j.thorsurg.2018.09.004_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Once-weekly rifapentine and isoniazid versus twice-weekly rifampin and isoniazid in the continuation phase of therapy for drug-susceptible pulmonary tuberculosis: a prospective, randomized clinical trial among HIV-negative persons","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1164\/rccm.200511-1834OC","article-title":"Lack of weight gain and relapse risk in a large tuberculosis treatment trial","volume":"174","author":"Khan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib23","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/cid\/cix686","article-title":"Time to sputum culture conversion and treatment outcomes among patients with isoniazid-resistant tuberculosis in Atlanta, Georgia","volume":"65","author":"Schechter","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"Jindani","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib25","unstructured":"World Health Organization. WHO treatment guidelines for drug resistant tuberculosis. Geneva (Switzerland): WHO; 2016."},{"key":"10.1016\/j.thorsurg.2018.09.004_bib26","unstructured":"Drug-Resistant Tuberculosis, a survival guide for clinicians 3rd edition. 2016. Available at: http:\/\/www.currytbcenter.ucsf.edu\/products\/view\/drug-resistant-tuberculosis-survival-guide-clinicians-3rd-edition. Accessed October 7, 2018."},{"key":"10.1016\/j.thorsurg.2018.09.004_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/AnnalsATS.201510-690BC","article-title":"Choice between levofloxacin and moxifloxacin and multidrug-resistant tuberculosis treatment outcomes","volume":"13","author":"Kang","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib28","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0140-6736(14)62002-X","volume":"385","author":"Dawson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.5588\/ijtld.17.0468","article-title":"The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?","volume":"21","author":"Reuter","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/resp.13345","article-title":"New drugs and regimens for tuberculosis","author":"Chang","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.14.0100","article-title":"Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients","volume":"18","author":"Aung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijid.2016.10.021","article-title":"Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings","volume":"56","author":"Sotgiu","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib34","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1183\/13993003.01646-2015","article-title":"Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China","volume":"47","author":"Berry","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12941-016-0156-y","article-title":"Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Agyeman","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00387-2017","article-title":"Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study","volume":"49","author":"Borisov","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1164\/rccm.200503-417OC","article-title":"Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis","volume":"173","author":"Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/cid\/cix121","article-title":"Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and metaanalysis","volume":"64","author":"Johnston","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jamainternmed.2018.0141","article-title":"Daily vs intermittent antituberculosis therapy for pulmonary tuberculosis in patients with hiv: a randomized clinical trial","volume":"178","author":"Gopalan","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib40","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1086\/324506","article-title":"The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project","volume":"33","author":"DeMaio","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib41","first-page":"779","article-title":"Videophone utilization as an alternative to directly observed therapy for tuberculosis","volume":"14","author":"Krueger","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib42","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.5588\/ijtld.14.0923","article-title":"Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study","volume":"19","author":"Garfein","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.thorsurg.2018.09.004_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01696-17","article-title":"False-positive Xpert MTB\/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes","volume":"56","author":"Theron","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0036-1572559","article-title":"Mycobacterial lung disease complicating HIV infection","volume":"37","author":"Haas","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1473-3099(14)70733-9","article-title":"Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial","volume":"14","author":"Mfinanga","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1164\/rccm.200509-1529OC","article-title":"Treatment outcomes of patients with HIV and tuberculosis","volume":"175","author":"Nahid","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib47","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis","volume":"52","author":"Torok","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-157-5-201209040-00004","article-title":"The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial","volume":"157","author":"Naidoo","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib50","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5588\/ijtld.13.0726","article-title":"Impact of chronic renal failure on anti-tuberculosis treatment outcomes","volume":"18","author":"Baghaei","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.thorsurg.2018.09.004_bib53","article-title":"Corticosteroids for managing tuberculous meningitis","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1407380","article-title":"Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis","volume":"371","author":"Mayosi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/598504","article-title":"Adalimumab treatment of life-threatening tuberculosis","volume":"48","author":"Wallis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thorsurg.2018.09.004_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cid\/civ841","article-title":"A\u00a0paradoxical treatment for a paradoxical condition: infliximab use in three cases of mycobacterial IRIS","volume":"62","author":"Hsu","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412718301300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412718301300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:31:38Z","timestamp":1761546698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412718301300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1547412718301300"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2018.09.004","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Medical Management of Pulmonary Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}